Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 20, 2022--
The "Joint Pain Injections Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global joint pain injections market.
This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the joint pain injections market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
The global joint pain injections market is expected to grow from $4.20 billion in 2021 to $4.63 billion in 2022 at a compound annual growth rate (CAGR) of 10.17%. The joint pain injections market is expected to reach $6.36 billion in 2026 at a CAGR of 8.25%.
Companies Mentioned
Reasons to Purchase
The joint pain injections market consists of sales of joint pain injections and products by entities (organizations, sole traders, and partnerships) that are used to relieve joint pain and inflammation quickly through non-surgical treatments. Joint pain injections reduce inflammation and discomfort and are typically injected directly into the joint for pain relief. Joint pain is very frequent among the elderly or as a result of pre-existing medical problems or disorders. It can happen as a result of musculoskeletal illnesses such as arthritis, which causes pain and inflammation.
The main types of injection for joint pain includes steroid joint injection, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections and others. The steroid joint injection are anti-inflammatory medications that are used to treat a joint pain. Steroid joint injections, also called corticosteroid injections, help to reduce inflammation in the people with rheumatoid arthritis and other types of inflammatory arthritis. Joint pain injection are used to for various types of joints including hip joint, knee and ankle, shoulder and elbow, facet joints of the spine and others. These are mainly distributed though hospital pharmacies, retail pharmacies, online pharmacies.
North America was the largest region in the joint pain injections market in 2021. The regions covered in the joint pain injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The joint pain injections market research report is one of a series of new reports that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rise in the prevalence of arthritis and musculoskeletal disorders will propel the growth of the joint pain injections market. Musculoskeletal disorders are the biggest cause of disability worldwide, with low back pain being the single most common cause of impairment in 160 nations. Patients are taking injections for pain relief and inflammatory condition.
New product development is a key trend gaining popularity in the joint pain injections market. Major companies operating in the join pain injections sector are focused on new product innovations to meet consumer demand and strengthen their position.
The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
For more information about this report visit https://www.researchandmarkets.com/r/cl1z24
View source version on businesswire.com:https://www.businesswire.com/news/home/20220920005904/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/20/2022 09:46 AM/DISC: 09/20/2022 09:47 AM
http://www.businesswire.com/news/home/20220920005904/en